跳至主要内容
临床试验/CTRI/2023/02/049663
CTRI/2023/02/049663已完成3 期

Clinical evaluation of Thippili Legiam (Internal) for the management of Uthiravatha Suronitham ( Rheumatoid Arthritis)

ational Institute of Siddha0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adults with rheumatoid arthritis based on EULAR/ACR score > 6/10
  • Patients who are willing to attend OPD or willing for admission IPD
  • Patients who are willing to undergo Radiological investigation and other laboratory investigation
  • Patient who are willing to sign the informed consent stating that he/ she will consciously stick to the treatment during 48 days but can stop opt out of the trail of his /her own conscious discretion

排除标准

  • Pregnancy and lactating mother
  • Uncontrolled Diabetes mellitus
  • k/c/o Any other arthritis
  • History of trauma
  • Extra articular involvement of Rheumatoid arthritis
  • Characteristic deformities of hands and feet in Rheumatoid arthritis

研究者

相似试验